Back to Walleye Capital LLC Walleye Capital LLC

INBXINBX

Showing 3 of 4 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in Inhibrx Biosciences, Inc.

No. Walleye Capital exited its INBX (Inhibrx Biosciences) position in Q1 2025. Its Q4 2024 13F listed 579,999 shares worth $8.9M. Walleye Capital already held INBX in its Q2 2024 13F, the earliest on record, and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$8.6M

Total Shares Change

-549,999

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$13.99
0
2024-Q4
Increased
579,999
+5.5%
$8.9M0.0%$15.40
29
2024-Q3
Increased
549,999
+15.8%
$8.6M0.0%$15.52
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used